United Capital Financial Advisors’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-19,967
Closed -$498K 1373
2019
Q3
$498K Sell
19,967
-63
-0.3% -$1.8K ﹤0.01% 953
2019
Q2
$598K Buy
20,030
+28
+0.1% +$817 ﹤0.01% 985
2019
Q1
$536K Sell
20,002
-2
-0% -$61 ﹤0.01% 959
2018
Q4
$612K Hold
20,004
﹤0.01% 850
2018
Q3
$701K Hold
20,004
﹤0.01% 872
2018
Q2
$541K Buy
20,004
+5,805
+41% +$136K ﹤0.01% 929
2018
Q1
$291K Hold
14,199
﹤0.01% 1105
2017
Q4
$259K Sell
14,199
-45
-0.3% -$891 ﹤0.01% 1159
2017
Q3
$319K Hold
14,244
﹤0.01% 1095
2017
Q2
$345K Buy
14,244
+22
+0.2% +$468 ﹤0.01% 1031
2017
Q1
$272K Buy
14,222
+25
+0.2% +$438 ﹤0.01% 1077
2016
Q4
$278K Buy
14,197
+35
+0.2% +$634 ﹤0.01% 1081
2016
Q3
$224K Buy
+14,162
New +$218K ﹤0.01% 1159

Other funds holding ATRC

United Capital Financial Advisors's ATRC Position: Q4 2019 in Review

United Capital Financial Advisors sold out of AtriCure (ATRC) in Q4 2019, closing a stake of 19,967 shares — an estimated $498K sold.

United Capital Financial Advisors first reported a position in ATRC in Q3 2016 and held it in 13 quarters. The position peaked at $701K in Q3 2018. 141 funds tracked by Wall St. Rank hold ATRC as of Q4 2019.

  • United Capital Financial Advisors reported no remaining AtriCure position as of Q4 2019 after selling out during the quarter.
  • United Capital Financial Advisors sold 19,967 AtriCure shares in Q4 2019, an estimated $498K.
  • United Capital Financial Advisors first reported a position in AtriCure in Q3 2016 and held it in 13 quarters.
  • United Capital Financial Advisors's AtriCure position peaked at $701K in Q3 2018.
  • 141 funds tracked by Wall St. Rank held AtriCure as of Q4 2019.

Based on United Capital Financial Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.